News | News By Subject | News by Disease News By Date | Search News

Biotechnology News Articles on Industry Topics

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
GlaxoSmithKline (GSK) May Separate Businesses     7/28/2014
Bay Area's PaxVax, Inc. Reels In Up To $60 Million Financing     7/28/2014
FDA Rejects Redwood City's AcelRx Pharmaceuticals (ACRX) Painkiller Dispensing Device; Stock Plunges -34.35% At 9:37AM ET     7/28/2014
Zealand Pharma  (ZEAL.CO), Boehringer Ingelheim Corporation Strike $402 Million Peptide Pact     7/28/2014
AstraZeneca PLC (AZN) Taps Roche (RHHBY) For New Blood-Based Cancer Drug Tests     7/28/2014
Clinuvel Snags A $95 Million Takeover Bid From New York-Based Retrophin, Inc. (RTRX)     7/28/2014
Confirmed: Reckitt Benckiser Plc (RB.L) To Spin Off Heroin Treatment Business     7/28/2014
FDA Approves Purdue Pharma L.P.’s Hard-to-Abuse Narcotic Painkiller     7/28/2014
Rumor: Hospira, Inc. May Buy Danone's Medical-Nutrition Unit For $5 Billion     7/28/2014
AstraZeneca PLC (AZN), QIAGEN N.V. (QGEN) Strike Lung Cancer Diagnostic Pact For Patients Suitable For Treatment With IRESSA     7/28/2014
Celsion Corporation (CLSN) Shows Off Positive ThermoDox® Data In Primary Liver Cancer Patients     7/28/2014
Biodel Inc. (BIOD) Enters Into $15 Million Equity Commitment With Lincoln Park Capital     7/28/2014
Management Reshuffle At Ranbaxy Laboratories (RANBAXY.BO): Arno Gessner Promoted, New R&D Head Named     7/28/2014
American Diabetes Association Announces Interim CEO     7/28/2014
Bristol-Myers Squibb Company (BMY) Taps Bay Area's Redwood City For Expansion, Pharma Giant To Increase Workforce     7/25/2014

Featured Stories
Allergan Inc. (AGN) Layoffs: Employees Tell Their Side Of The Story     7/28/2014
Layoffs Make Allergan Inc. (AGN), Microsoft CEOs Look Like Heroes—And That's Why Corporate America Is Sick     7/28/2014
Why Men Like Nice Women And Why Women Like Bad Boys, University of Rochester Study     7/28/2014
Politicizing Gilead Sciences, Inc. (GILD)'s R&D Solvadi Costs Is A Reckless And Dangerous Misadventure     7/28/2014
Slow Walking Speed And Memory Issues Linked To Early Signs Of Dementia, Albert Einstein College of Medicine Study     7/28/2014
20 Top-Paid Research Institute Leaders Of 2014     7/28/2014
3 Future Biotech Blockbusters To Watch?     7/28/2014
Google Inc.'s Next Project: The Human Body     7/28/2014
Shift Work Linked To Heightened Risk Of Type 2 Diabetes, Occupational & Environmental Medicine Reveals     7/28/2014
Novartis AG (NVS) Layoffs: Game-Changing Tips For Today’s Job Seeker     7/25/2014
3 Quotes From Johnson & Johnson (JNJ)'s Conference Call You Need To Read     7/25/2014
AbbVie (ABBV) Trod Cautiously In Inversion Takeover Bid To Woo Drug Maker Shire     7/25/2014
4 Ways Gilead Sciences, Inc. (GILD)’s Earnings Will Impact Every American     7/25/2014
The Ingredients Of "All Natural Foods" Will Terrify You     7/25/2014
Scientists To Be Given Compounds Discarded By Pharma Companies     7/25/2014

More News
Aqua Pharmaceuticals Announces FDA Approval Of ACTICLATE™ (Doxycycline Hyclate USP) Tablets, 150 Mg And 75 Mg     7/28/2014
TetraPhase Pharmaceuticals Completes Enrollment Of IGNITE 1 Eravacycline Phase 3 Clinical Trial in Complicated Intra-abdominal Infections     7/28/2014
Incyte Corporation (INCY) Release: Jakafi® (ruxolitinib) Product Label Expanded To Include Overall Survival Data And Additional Safety And Dosing Information     7/28/2014
Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427     7/28/2014
Retroscreen Conducts Landmark hVIVO Human Challenge Model Study Of AL-8176 In RSV For Alios BioPharma     7/28/2014
MorphoSys AG Provides Update On The Company's Proprietary Drug Portfolio     7/28/2014
Medivir AB (MVRBF): Phase II COSMOS Study Results Published In Lancet On World Hepatitis Day     7/28/2014
Phase 2 COSMOS Study Results Published In The Lancet Demonstrate Efficacy And Safety Of Janssen’s Once-Daily Simeprevir In All Oral 12-Week Combination With Sofosbuvir For Genotype 1 Chronic Hepatitis C     7/28/2014
ERYtech Pharma Announces Enrollment Of First Patient In Phase II Study Of ERY-ASP In Pancreatic Cancer     7/28/2014
Quark Pharmaceuticals Inc. Reports Favorable Results From Phase 2 Clinical Trial Evaluating Investigational Sirna QPI-1002     7/28/2014
Lorus Therapeutics Inc. (LRP) Receives FDA Clearance Of IND To Initiate LOR-253 Clinical Program In Patients With AML, MDS And Other Blood Cancers     7/28/2014
Stemline Therapeutics, Inc. (STML) Announces Opening Of SL-401 Corporate IND And Start Of Clinical Trials In BPDCN And AML     7/28/2014
Cytonet’s Liver Cell Therapy May Be Effective In Stabilizing Children With Severe Urea Cycle Disorders Awaiting Liver Transplant     7/28/2014
Transplant Genomics Release: Studies Presented At World Transplant Congress Support Development Of Biomarker Tests Aimed At Improving Transplant Recipient Care     7/28/2014
Variation Biotechnologies Inc. And Paulson Capital Announce Completion Of Merger     7/28/2014
Welichem Biotech Inc. (WBI.V) Ends Effort To Re-Acquire China Rights To Psoriasis Treatment     7/28/2014
PaxVax, Inc. Acquires FDA-Approved Typhoid Vaccine Vivotif     7/28/2014
CN Bio Innovations Marks World Hepatitis Day By Signing Research Agreement With Imperial College London     7/28/2014
MC10 & UCB, Inc. (UCBJF.PK) Partner For Innovative Solutions For Patients With Neurological Disorders.     7/28/2014
CANbridge Life Sciences And EUSA Pharma Form Agreement To Commericalize Caphosol® In China     7/28/2014
Targeted Medical Pharma Agrees To Sponsor A Clinical Trial Conducted By The United States Army And Henry M. Jackson Foundation For The Advancement Of Military Medicine     7/28/2014
Upsher-Smith Laboratories Galaxy™ Portfolio Of Antiepileptic Drugs Now Available     7/28/2014
Perrigo Company (PRGO) Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0%     7/28/2014
Veloxis Pharmaceuticals A/S (VELO) Release: Envarsus® Receives European Marketing Authorization For Treatment Of Both Kidney And Liver Transplant Patients     7/28/2014
Advaxis, Inc. Receives Notice Of Allowance For Cancer Immunotherapies Patent In Japan     7/28/2014
VGTI Florida Researcher Invents Potential Breakthrough Antiviral Compounds For Prevention Of Mosquito-Borne Illnesses     7/28/2014
Oxford Finance Closes $8 Million Senior Debt Facility With Natrix Separations, Inc.     7/28/2014
TNI BioTech, Files Definitive Proxy Materials; Mails Letter Urging Shareholders To Vote The Proxy Card     7/28/2014
Batu Biologics Strategy For FDA Approval Of Lung Cancer Immunotherapy Featured In San Diego Business Journal     7/28/2014
New England Research Institutes Double-Certified As Women's Business Enterprise     7/28/2014
PPD, Inc. (PPDI) Adds Customer-Focused Strategic Leader To Drive Client Success     7/28/2014
FEI Company Adds Phase Plate Technology And Titan Halo TEM To Its Structural Biology Product Portfolio     7/28/2014
The Upsher-Smith Laboratories Galaxy™ Portfolio Of Antiepileptic Drugs Now Available     7/28/2014
Immune Design Corporation (IMDZ) Announces Filing Of New Lawsuit By Theravectys SA     7/28/2014
FEI Company Adds Phase Plate Technology And Titan Halo Tem To Its Structural Biology Product Portfolio     7/28/2014
VigeneTech Releases New Powerful Software For Flow Cytometry Data Analysis     7/28/2014
AVANIR Pharmaceuticals (AVNR) Announces Date Of Fiscal 2014 Third Quarter Financial Results And Conference Call     7/28/2014
ANI Pharmaceuticals, Inc. Schedules Conference Call For Second Quarter 2014 Financial Results     7/28/2014
Array BioPharma, Inc. (ARRY) To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 On August 12, 2014     7/28/2014
Agios Pharmaceuticals (AGIO) To Webcast Conference Call Of Second Quarter 2014 Financial Results On August 7, 2014     7/28/2014
Amgen (AMGN) Announces 2014 Third Quarter Dividend     7/28/2014
CTI BioPharma To Report Second Quarter 2014 Financial Results On August 4, 2014     7/28/2014
Depomed, Inc. (DEPO) To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014     7/28/2014
Epizyme (EPZM) To Report Second Quarter Financial Results And Provide Corporate Update On August 13, 2014     7/28/2014
InterMune, Inc. (ITMN) To Release Second Quarter Financial Results On August 6     7/28/2014
Webcast Alert: Isis Pharmaceuticals, Inc. (ISIS)' Second Quarter 2014 Financial Results Conference Call     7/28/2014
PDL BioPharma, Inc. (PDLI) To Announce Second Quarter 2014 Financial Results On August 11, 2014     7/28/2014
Repligen Corporation (RGEN) To Report Second Quarter 2014 Financial Results     7/28/2014
Rockwell Medical (RMTI) Schedules 2nd Quarter 2014 Investor Conference Call     7/28/2014
Inform Genomics Announces Appointment Of Carl De Moor, Phd, As Chief Technology Officer     7/28/2014
Egalet Appoints Jeffrey M. Dayno, M.D. As Chief Medical Officer     7/28/2014
ImaginAb, Inc. Appoints Roger Crystal, MD As Vice President of Business Development     7/28/2014
Arthur J. Tipton, Ph.D., Named President Of Controlled Release Society     7/28/2014
Amarantus BioSciences, Inc. Appoints Donald D. Huffman To Board Of Directors     7/28/2014
ELC Group Appoints Head Of Regulatory Affairs For Russia And CIS     7/28/2014
St. Jude Children's Research Hospital Names Tri Delta Fraternity Partner Of The Year     7/28/2014
Corporate Governance Developments At BIOASTER, Institute For Technology Research In Health     7/28/2014
REGiMMUNE To Present Its Method For Long-Term Tolerance In Organ Transplantation At World Transplant Congress In San Francisco     7/28/2014
Cubist Pharmaceuticals, Inc. (CBST) To Present At August Investor Conference     7/28/2014

Career Tips
Novartis AG (NVS) Layoffs: Game-Changing Tips For Today’s Job Seeker     7/25/2014
Half Of Biotech Employees Dissatisfied With Their Employer     7/24/2014
5 Overused Phrases To Avoid Putting On Your Resume     7/24/2014
9 Proofreading Steps Every Job Seeker Should Follow     7/24/2014
Questions To Never Ask At A Job Interview     7/24/2014
5 Mistakes That Make Your Emails Unprofessional     7/24/2014
Job Seekers: No, The Thank You Email Is Not Dead     7/24/2014
5 Most Promising Biotech Jobs By 2022     7/10/2014
6 Smart Solutions For Customizing Your Resume     7/10/2014
7 Worst Things About Job Interviews     7/10/2014
5 Tips For Standing Out At A New Job (And Fit In Too)     7/10/2014
7 Reasons Your Coworkers Don’t Trust You     7/10/2014
Surprising Things You Didn't Know You Could Negotiate     7/10/2014
Revealed: The Biggest Fears For The Newest Job Seekers     6/26/2014
3 Steps To Enhancing Your Resume In Under 20 Minutes     6/26/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->